Last updated: 19 May 2021 at 4:09pm EST

Malcolm Fairbairn Net Worth




The estimated Net Worth of Malcolm Fairbairn is at least $1.22 Million dollars as of 19 May 2021. Malcolm Fairbairn owns over 10,000 units of Tff Pharmaceuticals Inc stock worth over $21,700 and over the last 5 years Malcolm sold TFFP stock worth over $1,195,500.

Malcolm Fairbairn TFFP stock SEC Form 4 insiders trading

Malcolm has made over 2 trades of the Tff Pharmaceuticals Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Malcolm bought 10,000 units of TFFP stock worth $89,500 on 19 May 2021.

The largest trade Malcolm's ever made was selling 75,000 units of Tff Pharmaceuticals Inc stock on 11 November 2020 worth over $1,195,500. On average, Malcolm trades about 21,250 units every 47 days since 2020. As of 19 May 2021 Malcolm still owns at least 10,000 units of Tff Pharmaceuticals Inc stock.

You can see the complete history of Malcolm Fairbairn stock trades at the bottom of the page.



What's Malcolm Fairbairn's mailing address?

Malcolm's mailing address filed with the SEC is 2600 VIA FORTUNA, SUITE 360, , AUSTIN, TX, 78746.

Insiders trading at Tff Pharmaceuticals Inc

Over the last 5 years, insiders at Tff Pharmaceuticals Inc have traded over $27,239,579 worth of Tff Pharmaceuticals Inc stock and bought 1,894,491 units worth $5,305,961 . The most active insiders traders include Therapeutics, Inc. Lung, Aaron G.L. Fletcher, and Harlan F Weisman. On average, Tff Pharmaceuticals Inc executives and independent directors trade stock every 25 days with the average trade being worth of $174,967. The most recent stock trade was executed by Harlan F Weisman on 15 August 2023, trading 600,000 units of TFFP stock currently worth $150,000.



What does Tff Pharmaceuticals Inc do?

tff pharmaceuticals, inc. is a clinical-stage biopharma company focused on developing and commercializing drug products based on its patented thin film freezing (tff) technology. our patented thin film freezing (tff) platform makes it possible to turn more molecules into inhalable therapies. this novel technology provides high absorption and yield, uniform particle size, gentle process and endless possibilities. tff pharmaceuticals has two lead drug candidates: voriconazole inhalation powder and tac-lac inhalation powder. the company plans to add to this pipeline by collaborating with large pharmaceutical partners. the tff platform is protected by 42 patents issued or pending in the us and internationally.



What does Tff Pharmaceuticals Inc's logo look like?

Tff Pharmaceuticals Inc logo

Complete history of Malcolm Fairbairn stock trades at Tff Pharmaceuticals Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
19 May 2021 Malcolm Fairbairn
Director
Buy 10,000 $8.95 $89,500
19 May 2021
10,000
11 Nov 2020 Malcolm Fairbairn
Director
Sale 75,000 $15.94 $1,195,500
11 Nov 2020
0


Tff Pharmaceuticals Inc executives and stock owners

Tff Pharmaceuticals Inc executives and other stock owners filed with the SEC include: